PASG - Passage BIO, Inc.
8.4
0.280 3.333%
Share volume: 66,082
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$8.12
0.28
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-13-2024 | 03-04-2025 | 05-13-2025 | 11-10-2025 | 03-03-2026 | |
| Assets | ||||||||
| Total Assets | 140.531 M | 125.392 M | 111.752 M | 102.412 M | 86.006 M | 74.160 M | 62.281 M | |
| Current Assets | 108.293 M | 95.000 M | 87.216 M | 78.815 M | 66.669 M | 55.730 M | 47.762 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 67.752 M | 67.003 M | 52.534 M | 39.183 M | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 36.773 M | 24.770 M | 32.292 M | 37.573 M | 63.357 M | 52.773 M | 46.303 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 14.489 M | 13.054 M | 10.036 M | 9.331 M | 5.523 M | 5.159 M | 4.107 M | |
| Other Assets | 17.749 M | 17.338 M | 14.500 M | 14.266 M | 13.814 M | 13.271 M | 10.412 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 140.531 M | 125.392 M | 111.752 M | 102.412 M | 86.006 M | 74.160 M | 62.281 M | |
| Total liabilities | 35.648 M | 34.835 M | 39.036 M | 41.151 M | 39.300 M | 43.040 M | 43.526 M | |
| Total current liabilities | 12.841 M | 12.385 M | 16.951 M | 19.363 M | 17.825 M | 22.245 M | 23.083 M | |
| Accounts Payable | 1.687 M | 621.000 K | 1.489 M | 742.000 K | 1.458 M | 952.000 K | 1.113 M | |
| Other liabilities | 22.807 M | 22.450 M | 22.085 M | 21.788 M | 21.475 M | 20.795 M | 20.443 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 22.807 M | 22.450 M | 22.085 M | 21.788 M | 21.475 M | 20.795 M | 20.443 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 104.883 M | 90.557 M | 72.716 M | 61.261 M | 46.706 M | 31.120 M | 18.755 M | |
| Common stock | 716.131 M | 717.794 M | 719.194 M | 720.488 M | 721.346 M | 722.894 M | 723.512 M | |
| Retained earnings | -611.179 M | -627.170 M | -646.510 M | -659.235 M | -674.640 M | -691.774 M | -704.757 M |